These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. New treatment options for immune-mediated hematological disorders. Dierickx D; De Rycke A; Vanderschueren S; Delannoy A Eur J Intern Med; 2008 Dec; 19(8):579-86. PubMed ID: 19046722 [TBL] [Abstract][Full Text] [Related]
30. [Isotopes used in the diagnosis of hematological disorders; determination of siderokinetic disorders with Fe59]. GARBY L; SJOLIN S Nord Med; 1958 Jan; 59(1):19-21. PubMed ID: 13517579 [No Abstract] [Full Text] [Related]
31. Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders. Zhang LJ; Shin ES; Yu ZX; Li SB Chin Med J (Engl); 2007 Nov; 120(22):2002-5. PubMed ID: 18067786 [TBL] [Abstract][Full Text] [Related]
32. [Extrahepatic manifestations of infection with hepatitis C virus]. García Ferrera WO; Nodarse Cuní H; Moredo Romo E Rev Gastroenterol Peru; 2009; 29(3):254-61. PubMed ID: 19898598 [TBL] [Abstract][Full Text] [Related]
33. [Registration of hematological disorders by the Kyushu Hematology Organization for Treatment (K-HOT) Study Group]. Kawano R; Utsunomiya A; Matsuoka H; Kawano F; Ikeda S; Izumi Y; Tsukada J; Shibuya T; Okamura S; Uike N; Nagano M; Tamura K; Rinsho Ketsueki; 2004 Jun; 45(6):478-80. PubMed ID: 15287525 [TBL] [Abstract][Full Text] [Related]
34. Hematological disorders. Paris DA; Cotter AJ; Emerg Med Serv; 2005 Aug; 34(8):143-51; quiz 180-1. PubMed ID: 16176045 [No Abstract] [Full Text] [Related]
35. Toxicity of small cell lung cancer treatment. Casas F; Viñolas N Hematol Oncol Clin North Am; 2004 Apr; 18(2):461-81. PubMed ID: 15094182 [No Abstract] [Full Text] [Related]
36. Drug-induced respiratory disease in patients with hematological diseases. Camus P; Costabel U Semin Respir Crit Care Med; 2005 Oct; 26(5):458-81. PubMed ID: 16267698 [TBL] [Abstract][Full Text] [Related]
37. [Changes in the blood in workers exposed to chronic effects of mercaptophos]. IUSHKEVICH LB Probl Gematol Pereliv Krovi; 1961 Jul; 6():35-6. PubMed ID: 13718197 [No Abstract] [Full Text] [Related]
38. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC). Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002 [TBL] [Abstract][Full Text] [Related]
39. [Iatrogenic hematological syndromes]. GONZALEZ CRUZ A Med Esp; 1959 Sep; 42():190-203. PubMed ID: 13850984 [No Abstract] [Full Text] [Related]
40. Usefulness of oral cyanocobalamin therapy in severe hematologic manifestations related to vitamin B12 deficiency. Andrès E; Noel E; Coca C; Fothergill H; Caro-Sampara F; Maloisel F; Blicklé JF Ann Pharmacother; 2004 Jun; 38(6):1086-7. PubMed ID: 15122008 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]